Until large prospective longitudinal studies of patients with PA and other low-renin hypertension will elucidate the optimal parameters for guiding medical therapy titration, incorporating renin targets within PA practice guidelines is likely to benefit patient care. This evidence concerns the gene REN and Hypertension.